Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.41
(-1.22%)
HKD 0.41
(-1.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.24 Billion CNY | 2.96% |
| 2022 | 1.2 Billion CNY | 26.16% |
| 2021 | 956.51 Million CNY | 12.89% |
| 2020 | 847.32 Million CNY | 14.85% |
| 2019 | 737.73 Million CNY | 0.78% |
| 2018 | 732.01 Million CNY | -0.05% |
| 2017 | 732.38 Million CNY | 8.28% |
| 2016 | 676.35 Million CNY | -7.37% |
| 2015 | 730.2 Million CNY | 5.48% |
| 2014 | 692.29 Million CNY | 2.14% |
| 2013 | 677.77 Million CNY | 2.34% |
| 2012 | 662.29 Million CNY | -0.26% |
| 2011 | 664 Million CNY | 5.21% |
| 2010 | 631.09 Million CNY | 4.24% |
| 2009 | 605.45 Million CNY | 5.45% |
| 2008 | 574.15 Million CNY | 3.13% |
| 2007 | 556.73 Million CNY | 10.81% |
| 2006 | 502.4 Million CNY | 26.53% |
| 2005 | 397.05 Million CNY | -5.2% |
| 2004 | 418.83 Million CNY | 7.51% |
| 2003 | 389.58 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.26 Billion CNY | 0.0% |
| 2024 Q1 | 1.26 Billion CNY | 2.11% |
| 2023 Q3 | 1.24 Billion CNY | -2.69% |
| 2023 FY | 1.24 Billion CNY | 2.96% |
| 2023 Q4 | 1.24 Billion CNY | 0.0% |
| 2023 Q1 | 1.27 Billion CNY | 5.8% |
| 2023 Q2 | 1.27 Billion CNY | 0.0% |
| 2022 Q1 | 1.14 Billion CNY | 20.17% |
| 2022 Q2 | 1.14 Billion CNY | 0.0% |
| 2022 Q3 | 1.2 Billion CNY | 4.99% |
| 2022 FY | 1.2 Billion CNY | 26.16% |
| 2022 Q4 | 1.2 Billion CNY | 0.0% |
| 2021 Q2 | 889.05 Million CNY | 0.0% |
| 2021 FY | 956.51 Million CNY | 12.89% |
| 2021 Q1 | 889.05 Million CNY | 4.92% |
| 2021 Q3 | 956.51 Million CNY | 7.59% |
| 2021 Q4 | 956.51 Million CNY | 0.0% |
| 2020 Q2 | 756.65 Million CNY | 0.0% |
| 2020 Q3 | 847.32 Million CNY | 11.98% |
| 2020 Q4 | 847.32 Million CNY | 0.0% |
| 2020 Q1 | 756.65 Million CNY | 2.56% |
| 2020 FY | 847.32 Million CNY | 14.85% |
| 2019 Q3 | 737.73 Million CNY | 0.1% |
| 2019 Q2 | 737.01 Million CNY | 0.0% |
| 2019 Q4 | 737.73 Million CNY | 0.0% |
| 2019 FY | 737.73 Million CNY | 0.78% |
| 2019 Q1 | 737.01 Million CNY | 0.68% |
| 2018 Q4 | 732.01 Million CNY | 0.0% |
| 2018 Q2 | 702.73 Million CNY | 0.0% |
| 2018 FY | 732.01 Million CNY | -0.05% |
| 2018 Q1 | 702.73 Million CNY | -4.05% |
| 2018 Q3 | 732.01 Million CNY | 4.17% |
| 2017 Q3 | 732.38 Million CNY | 6.23% |
| 2017 Q4 | 732.38 Million CNY | 0.0% |
| 2017 FY | 732.38 Million CNY | 8.28% |
| 2017 Q1 | 689.41 Million CNY | 1.93% |
| 2017 Q2 | 689.41 Million CNY | 0.0% |
| 2016 Q3 | 676.35 Million CNY | -1.36% |
| 2016 FY | 676.35 Million CNY | -7.37% |
| 2016 Q4 | 676.35 Million CNY | 0.0% |
| 2016 Q2 | 685.68 Million CNY | 0.0% |
| 2016 Q1 | 685.68 Million CNY | -6.1% |
| 2015 Q4 | 730.2 Million CNY | 0.0% |
| 2015 Q1 | 665.06 Million CNY | -3.93% |
| 2015 FY | 730.2 Million CNY | 5.48% |
| 2015 Q2 | 665.06 Million CNY | 0.0% |
| 2015 Q3 | 730.2 Million CNY | 9.8% |
| 2014 Q4 | 692.29 Million CNY | 0.0% |
| 2014 Q3 | 692.29 Million CNY | -5.63% |
| 2014 Q2 | 733.63 Million CNY | 0.0% |
| 2014 Q1 | 733.63 Million CNY | 8.24% |
| 2014 FY | 692.29 Million CNY | 2.14% |
| 2013 Q2 | 688.85 Million CNY | 0.0% |
| 2013 Q3 | 677.77 Million CNY | -1.61% |
| 2013 Q4 | 677.77 Million CNY | 0.0% |
| 2013 FY | 677.77 Million CNY | 2.34% |
| 2013 Q1 | - CNY | -100.0% |
| 2012 FY | 662.29 Million CNY | -0.26% |
| 2012 Q3 | - CNY | -100.0% |
| 2012 Q4 | 662.29 Million CNY | 0.0% |
| 2012 Q2 | 686.53 Million CNY | 0.0% |
| 2011 FY | 664 Million CNY | 5.21% |
| 2011 Q2 | 668.45 Million CNY | 0.0% |
| 2011 Q4 | 664 Million CNY | 0.0% |
| 2010 Q2 | 674.63 Million CNY | 0.0% |
| 2010 FY | 631.09 Million CNY | 4.24% |
| 2010 Q4 | 631.09 Million CNY | 0.0% |
| 2009 FY | 605.45 Million CNY | 5.45% |
| 2008 FY | 574.15 Million CNY | 3.13% |
| 2007 FY | 556.73 Million CNY | 10.81% |
| 2006 FY | 502.4 Million CNY | 26.53% |
| 2005 FY | 397.05 Million CNY | -5.2% |
| 2004 FY | 418.83 Million CNY | 7.51% |
| 2003 FY | 389.58 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 240.23 Million HKD | -417.209% |
| Lee & Man Chemical Company Limited | 7.02 Billion HKD | 82.323% |